MasterCraft, a sport boat manufacturer restructured by Wayzata Partners, announced terms for its IPO on Tuesday. The Vonore, TN-based company plans to raise $85 million by offering 6.1 million shares at a price range of $13 to $15. At the midpoint of the...read more
Dicerna Pharmaceuticals (DRNA) gained 207% and Ultragenyx (RARE) followed with a 101% first-day jump the next day as the biotech boom reached a new gear last week. Dicerna’s first-day return was the best since Baidu’s IPO in 2005 (+354%), and...read more
Malibu Boats, a leading performance sport boat manufacturer, raised $100 million by offering 7.1 million shares at $14, the midpoint of the range of $13 to $15. Malibu Boats plans to list on the NASDAQ under the symbol MBUU. Malibu Boats initially filed...read more
On a boat: MasterCraft sets terms for $85 million IPO
MasterCraft, a sport boat manufacturer restructured by Wayzata Partners, announced terms for its IPO on Tuesday. The Vonore, TN-based company plans to raise $85 million by offering 6.1 million shares at a price range of $13 to $15. At the midpoint of the...read more
US IPO Recap: Ultragenyx doubles and Dicerna triples in home-run week for biotech IPOs
Dicerna Pharmaceuticals (DRNA) gained 207% and Ultragenyx (RARE) followed with a 101% first-day jump the next day as the biotech boom reached a new gear last week. Dicerna’s first-day return was the best since Baidu’s IPO in 2005 (+354%), and...read more
Malibu Boats prices IPO at $14, the midpoint of the range
Malibu Boats, a leading performance sport boat manufacturer, raised $100 million by offering 7.1 million shares at $14, the midpoint of the range of $13 to $15. Malibu Boats plans to list on the NASDAQ under the symbol MBUU. Malibu Boats initially filed...read more
6 US IPOs planned for the week of Jan 27
The following IPOs are expected to price this week: Cara Therapeutics (CARA), a clinical-stage biotech developing a novel opioid pain medication, plans to raise $60...read more